Application 212446
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ICATIBANT ACETATE | ICATIBANT ACETATE | INJECTABLE;SUBCUTANEOUS | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-664 | ICATIBANT | ICATIBANT | Cipla USA Inc. | ANDA | Current |
| 69097-664 | ICATIBANT | ICATIBANT | Cipla USA Inc. | ANDA | Current |
| 69097-664 | ICATIBANT | ICATIBANT | Cipla USA Inc. | ANDA | Current |
| 70709-013 | SAJAZIR | ICATIBANT | Cycle Pharmaceuticals Ltd-Uk | ANDA | Current |
| 70709-013 | ICATIBANT | ICATIBANT | Cycle Pharmaceuticals Ltd-Uk | ANDA | Current |
| 70709-013 | SAJAZIR | ICATIBANT | Cycle Pharmaceuticals Ltd-Uk | ANDA | Current |